Literature DB >> 15888356

Thromboelastographic study of the effect of manipulation of central veins on coagulability of venous blood.

David A Mitchell1, Heather Gorton.   

Abstract

AIM: To measure whole blood coagulability in vitro using thromboelastography before and after direct and indirect manipulation of the internal jugular and subclavian veins.
METHODS: We studied 10 patients (American Society of Anaesthesiologists (ASA) grades I or II) with malignant disease of the head and neck who were having selective neck dissections. We excluded patients with diabetes, those who were being given any anticoagulant, those who were actively infected, and those with known coagulopathy. We took 3 ml samples of venous blood during insertion of a peripheral cannula, after insertion of a central venous cannula, and after dissection of the internal jugular vein. Thromboelastography was done on recalcified citrated samples within 1h of sampling. The variables r, k, alpha angle, and maximum amplitude were recorded at each point and the values before and after manipulation were compared using t-tests.
RESULTS: The only change was seen in the variable r, which showed an insignificant increase in coagulability.

Entities:  

Mesh:

Year:  2005        PMID: 15888356     DOI: 10.1016/j.bjoms.2004.08.024

Source DB:  PubMed          Journal:  Br J Oral Maxillofac Surg        ISSN: 0266-4356            Impact factor:   1.651


  2 in total

1.  Strategies for avoiding complications with vascularized bone flaps in head and neck microvascular reconstruction.

Authors:  David A Mitchell; Stephen P R Macleod
Journal:  Semin Plast Surg       Date:  2008-08       Impact factor: 2.314

Review 2.  Use of Thromboelastography and Rotational Thromboelastometry in Otolaryngology: A Narrative Review.

Authors:  Mathew K Marsee; Faisal S Shariff; Grant Wiarda; Patrick J Watson; Ali H Sualeh; Toby J Brenner; Max L McCoy; Hamid D Al-Fadhl; Alexander J Jones; Patrick K Davis; David Zimmer; Craig Folsom
Journal:  J Clin Med       Date:  2022-02-20       Impact factor: 4.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.